Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

Exagen Inc. - Common Stock (NQ:XGN)

4.490 +0.020 (+0.45%)
Streaming Delayed Price Updated: 4:00 PM EDT, Apr 17, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Exagen Inc. - Common Stock

< Previous 1 2 3 4 5 Next >
Why Opiant Pharmaceuticals Shares Are Trading Higher By 115%? Here Are 67 Stocks Moving In Tuesday's Mid-Day Session
Gainers SenesTech, Inc. (NASDAQ: SNES) shares surged 91.7% to $0.2751. SenesTech reported a 1-for-20 reverse stock split. 
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
Via Benzinga
Earnings Scheduled For May 11, 2022
Companies Reporting Before The Bell • Great Elm Capital (NASDAQ:GECC) is expected to report earnings for its first quarter. 
Via Benzinga
Exagen: Q4 Earnings Insights
Exagen (NASDAQ:XGN) reported its Q4 earnings results on Tuesday, March 22, 2022 at 04:00 PM. Here's what investors need to know about the announcement. Earnings Exagen... 
Via Benzinga
Exagen: Q3 Earnings Insights
Exagen (NASDAQ:XGN) reported its Q3 earnings results on Wednesday, November 10, 2021 at 04:05 PM. Here's what investors need to know about the announcement. Earnings Exagen... 
Via Benzinga
Pinterest To $23? Plus This Analyst Slashes PT On Neoleukin Therapeutics By More Than 90%
Rosenblatt raised the price target on Pinterest, Inc. (NYSE: PINS) from $21 to $23. Rosenblatt analyst Barton Crockett maintained a Neutral rating on the stock. Pinterest shares rose 2% to $24.91 in... 
Via Benzinga
Exagen Inc. Reports Third Quarter 2022 Results
Medicare Reimbursement Returns 
From Exagen Inc.
Via GlobeNewswire
Exagen Inc. to Participate in Fourth Quarter Investor Conferences
From Exagen Inc.
Via GlobeNewswire
Exagen to Announce Third Quarter 2022 Financial Results on November 14, 2022
From Exagen Inc.
Via GlobeNewswire
Earnings Scheduled For November 14, 2022
Companies Reporting Before The Bell • Opiant Pharma (NASDAQ:OPNT) is estimated to report quarterly loss at $1.49 per share on revenue of $3.68 million. 
Via Benzinga
Stocks That Hit 52-Week Lows On Monday
  During Monday's session, 101 companies made new 52-week lows. 
Via Benzinga
Exagen Announces Appointment of John Aballi as CEO
From Exagen Inc.
Via GlobeNewswire
Exagen Announces Appointment of Andrew L. Concoff MD, FACR, CAQSM, as Chief Innovation Officer
From Exagen Inc.
Via GlobeNewswire
Stocks That Hit 52-Week Lows On Monday
  Monday saw 825 companies set new 52-week lows. 
Via Benzinga
Short Interest Sector Focus: Healthcare Sector
As of the close of business on Friday, 9/23, we captured the Top 10 Highest Short Interest % stocks within the Healthcare Sector. The average short interest for stocks within the Healthcare sector... 
Via Benzinga
Short Interest Sector Focus: Healthcare Sector
As of the close of business on Monday, 8/29, we captured the Top 10 Highest Short Interest % stocks within the Healthcare Sector. The average short interest for stocks within the Healthcare sector... 
Via Benzinga
Exagen's Return On Capital Employed Overview
Exagen (NASDAQ:XGN) brought in sales totaling $8.96 million during Q2 according to data provided by Benzinga Pro. However, earnings decreased 29.57%, resulting in a loss of $13.31 million. 
Via Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
  
Via Benzinga
Stocks That Hit 52-Week Lows On Monday
On Monday, 198 companies reached new 52-week lows. 
Via Benzinga
Why Quoin Pharmaceuticals Plunged Over 62%; Here Are 120 Biggest Movers From Friday
Gainers 
Via Benzinga
Why Cooper-Standard Is Trading Higher By 70%, Here Are 81 Stocks Moving In Friday's Mid-Day Session
Gainers Assure Holdings Corp. (NASDAQ: IONM) shares jumped 88.8% to $3.9650 after jumping around 104% on Thursday. 
Via Benzinga
Exagen: Q1 Earnings Insights
Exagen (NASDAQ:XGN) reported its Q1 earnings results on Wednesday, May 11, 2022 at 04:00 PM. Here's what investors need to know about the announcement. Earnings Exagen beat estimated earnings by 1.64%,... 
Via Benzinga
Stocks That Hit 52-Week Lows On Monday
On Monday, 466 companies hit new 52-week lows. Noteworthy Highlights From Today's 52-Week Lows: The largest company by market cap to set a new 52-week low was... 
Via Benzinga
Exagen's Return On Capital Employed Overview
According to Benzinga Pro data, during Q4, Exagen (NASDAQ:XGN) posted sales of $12.69 million. Earnings were up 1.76%, but Exagen still reported an overall loss of $7.05 million.... 
Via Benzinga
Earnings Scheduled For March 22, 2022
Companies Reporting Before The Bell • GDS Holdings (NASDAQ:GDS) is projected to report quarterly loss at $0.18 per share on revenue of $338.69 million. • HUYA (... 
Via Benzinga
A Preview Of Exagen's Earnings
Exagen (NASDAQ:XGN) is set to give its latest quarterly earnings report on Tuesday, 2022-03-22. Here's what investors need to know before the announcement. Analysts estimate that... 
Via Benzinga
Stocks That Hit 52-Week Lows On Wednesday
Wednesday's session saw 107 companies set new 52-week lows. Points of Interest From Today's 52-Week Lows: Citigroup (NYSE:C) was the largest company by... 
Via Benzinga
Exagen Inc. (XGN) Q3 2021 Earnings Call Transcript
XGN earnings call for the period ending September 30, 2021. 
Via The Motley Fool
Topics Earnings
Exposures Financial
Looking Into Exagen's Return On Capital Employed
Exagen (NASDAQ:XGN) brought in sales totaling $12.77 million during Q2 according to data provided by Benzinga Pro. However, earnings decreased 3.14%, resulting in a loss of $5.74... 
Via Benzinga
85 Biggest Movers From Yesterday
Gainers Fulcrum Therapeutics, Inc. (NASDAQ: FULC) jumped 125.3% to close at $18.77 on Tuesday after the company announced positive interim results from the Phase 1 trial with FTX... 
Via Benzinga
< Previous 1 2 3 4 5 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.